The effects of chiglitazar and metformin on insulin resistance in women with a normal BMI and polycystic ovary syndrome: a randomized controlled study

Abstract Background Polycystic ovary syndrome (PCOS) affects both obese and normal-weight women, with limited treatment options available for the nonobese population. Metformin (MET), an insulin sensitizer, is used to ameliorate insulin resistance and associated reproductive endocrine metabolic dysf...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yining Yang, Yi Han, Jinhui Xu, Yijia Gao, Bing He
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-12-01
Saila:	BMC Endocrine Disorders
Gaiak:	Polycystic ovary syndrome Normal weight Metformin Chiglitazar Insulin resistance
Sarrera elektronikoa:	https://doi.org/10.1186/s12902-025-02082-0
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!